Arab Petroleum Investments Corporation (APICORP) a Multilateral Development Bank, rated Aa3 (stable outlook) by Moody’s, has mandated Crédit Agricole CIB, HSBC, J.P. Morgan, and Standard Chartered Bank as Joint Lead Managers and Bookrunners and Union National Bank as Co-Lead Manager to arrange a series of fixed income investor meetings in the U.K. and the U.S. commencing on Wednesday, 05 September 2018. A fixed rate 5 year benchmark U.S. Dollar-denominated senior unsecured Rule 144A / Regulation S bond transaction will follow, subject to market conditions. FCA/ICMA stabilisation applies.
MiFID II professional investors only / ECPs-only /no PRIIPs KID – Manufacturers’ target market (MIFID II product governance) is eligible counterparties and professional clients (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA.
THIS INFORMATION RELATES TO AN OFFERING OF SECURITIES OFFERED AND SOLD PURSUANT TO RULE 144A AND/OR REGULATION S (EXEMPTIONS FROM THE U.S. REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OF 1933) AND IS ONLY DIRECTED AT QUALIFIED INSTITUTIONAL BUYERS UNDER RULE 144A (“QIBs”) WHO ARE ALSO QUALIFIED PURCHASERS AS DEFINED IN SECTION 2(A)(51)(A) OF THE U.S. INVESTMENT COMPANY ACT OF 1940, AS AMENDED (“QPs”) OR TO NON-U.S. PERSONS OUTSIDE THE UNITED STATES OF AMERICA UNDER REGULATION S TO WHOM THE DISTRIBUTION OF THIS INFORMATION, WHETHER DIRECTLY OR INDIRECTLY, IS NOT OTHERWISE UNLAWFUL. THIS ANNOUNCEMENT IS NOT BEING MADE IN AND COPIES OF IT MAY NOT BE DISTRIBUTED OR SENT INTO THE UNITED STATES (EXCEPT THAT IT MAY BE SENT IN THE UNITED STATES DIRECTLY TO QIBs WHO ARE QPs), CANADA, AUSTRALIA OR JAPAN.
In connection with Section 309(B) of the Securities and Futures Act (Chapter 289) of Singapore (the “SFA”) and the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore (the CMP Regulations 2018), APICORP has determined, and hereby notifies all relevant persons (as defined in Section 309(A)(1) of the SFA), that the securities to which this announcement relates are prescribed capital markets products (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).
This communication is not an offer of securities for sale in the United States, Australia, Canada, Japan or any other jurisdiction where to do so would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this communication in any jurisdiction where action for that purpose is required. APICORP has not registered, and does not intend to register, securities in any of these jurisdictions and does not intend to conduct a public offering of securities in any of these jurisdictions. The securities referred to herein have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not be sold in the United States absent registration or an exemption from registration under the Securities Act. APICORP does not intend to register any of the securities in the United States or to conduct a public offering of the securities in the United States.
This communication does not constitute an offer of the securities to the public in the United Kingdom. This communication is being distributed to and is directed only at (i) persons who are outside the United Kingdom or (ii) persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) and (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “Relevant Persons”). Any investment activity to which this communication relates will only be available to and will only be engaged with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents.
This is an advertisement and not a prospectus for the purposes of EU Directive 2003/71/EC, as amended (the “Directive”) and/or Part IV of the Financial Services and Markets Act 2000. A prospectus will be prepared and made available in accordance with the Directive. Investors should not subscribe for or purchase any securities referred to in this advertisement except on the basis of information contained in the prospectus.